Core Areas Evaluated During Your Video Visit
Our oncologists review your specific disease biology, staging milestones, and genomic profiling to provide personalized, actionable clarity.
HER2 & Hormone Receptor Re-Evaluation
Evaluate HER2-low status (IHC 1+ or 2+/FISH negative) for eligibility for antibody-drug conjugates like trastuzumab deruxtecan (Enhertu).
Genomic Assay Interpretation
Review Oncotype DX Recurrence Score (RS) to determine definitive benefit vs futility of adjuvant chemotherapy in HR+/HER2- early breast cancer.
Surgical Margin & Reconstruction Review
Discuss clear vs close surgical margins, sentinel lymph node dissection vs axillary clearance, and immediate reconstruction options.
CDK4/6 Inhibitors & Endocrine Therapy
Evaluate adjuvant abemaciclib (Verzenio) or ribociclib (Kisqali) indications for high-risk early hormone receptor-positive disease.
What to Prepare Before Your Video Visit
Preparing these records in advance allows your oncologist to dive straight into strategy and clinical recommendations.
Pathology Reports
Biopsy results, immunohistochemistry (IHC) markers, and surgical operative records.
Scan Reports & DICOM
CT, MRI, or PET-CT reports plus raw imaging discs for cross-sectional screen share review.
Your Questions List
5 to 7 prioritized questions regarding treatment goals, toxicity risks, and trial options.
Frequently Asked Questions: Breast Cancer Video Consult
Clear clinical answers regarding visit expectations, record preparation, and treatment continuity.
Related Oncology Virtual Services
Explore adjacent clinical visit guides and multidisciplinary second opinions.
Video Consultation with a Board-Certified Oncologist
A direct video consultation enables cancer patients to consult top subspecialty oncologists without the physical strain, travel expenses, or multi-week delays of traveling to distant cancer centers.
What to Expect During an Oncology Video Visit
Maximize the value of your 30-45 minute oncology virtual visit by understanding the consultation structure, essential records, and highest-priority clinical questions.
Rare Cancer Online Teleconsultation
Access rare tumor subspecialists who treat high-volume cohorts of rare malignancies: soft tissue and bone sarcomas, neuroendocrine tumors (NETs), appendiceal carcinomas, salivary gland cancers, and molecularly driven ultra-rare neoplasms.
Multidisciplinary Second Opinion
Need a full tumor board slide re-review or DICOM over-read? Explore our written multidisciplinary second opinion panel.
Schedule Your Breast Cancer Video Consult Today
Connect directly with a board-certified oncologist. Complete your intake in 3 minutes, upload your records, and receive clarity within 24 to 48 hours for a transparent $199 flat fee.